koryu

editas medicine crispr/cas9 investment

看多
koryu 已更新   
NASDAQ:EDIT   Editas Medicine, Inc.
12
I enter long as long term investment in CRISPR/Cas9 technology.

There is still a patent battle going on, thats why there is the big dump in the chart.

Buying here feels like catching the knife, so buying slowly over time.


交易進行:
nice start. also watching NTLA
評論:
was lucky and got in at 13.40$

There was a bullish divergence on daily rsi. Now watching carefully if it is an additional inv h+s forming. Really like this stock. Ready to increase position if bottom is confirmed.

評論:
increasing position in this dip
評論:
pitchfork scenario
評論:
adjusted pitchfork and channel, fits really good! would be amazing bull market (must break out the channel!) definitly watch this
評論:
break out channel and horizontal resistance! <3
評論:
EW
評論:
bounced on the potential pitchfork and formed a weekly hammer candle which tested the long term downtrend in bullish manner
評論:
HODL the double up :D

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。